BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miles A, Cockburn J, Smith RA, Wardle J. A perspective from countries using organized screening programs. Cancer. 2004;101:1201-1213. [PMID: 15316915 DOI: 10.1002/cncr.20505] [Cited by in Crossref: 137] [Cited by in F6Publishing: 116] [Article Influence: 7.6] [Reference Citation Analysis]
Number Citing Articles
1 Jimbo M. Organizing Preventive Health Care in Men. Primary Care: Clinics in Office Practice 2006;33:237-46. [DOI: 10.1016/j.pop.2005.11.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Dominitz JA, Levin TR. What Is Organized Screening and What Is Its Value? Gastrointestinal Endoscopy Clinics of North America 2020;30:393-411. [DOI: 10.1016/j.giec.2020.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Senore C, Inadomi J, Segnan N, Bellisario C, Hassan C. Optimising colorectal cancer screening acceptance: a review. Gut 2015;64:1158-77. [DOI: 10.1136/gutjnl-2014-308081] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 8.9] [Reference Citation Analysis]
4 Zapka JG, Geller BM, Bulliard J, Fracheboud J, Sancho-garnier H, Ballard-barbash R. Print information to inform decisions about mammography screening participation in 16 countries with population-based programs. Patient Education and Counseling 2006;63:126-37. [DOI: 10.1016/j.pec.2005.09.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
5 Gupta S, Coronado GD, Argenbright K, Brenner AT, Castañeda SF, Dominitz JA, Green B, Issaka RB, Levin TR, Reuland DS, Richardson LC, Robertson DJ, Singal AG, Pignone M. Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit. CA Cancer J Clin 2020;70:283-98. [PMID: 32583884 DOI: 10.3322/caac.21615] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
6 Teh YC, Tan GH, Taib NA, Rahmat K, Westerhout CJ, Fadzli F, See MH, Jamaris S, Yip CH. Opportunistic mammography screening provides effective detection rates in a limited resource healthcare system. BMC Cancer 2015;15:405. [PMID: 25972043 DOI: 10.1186/s12885-015-1419-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
7 Sivaram S, Majumdar G, Perin D, Nessa A, Broeders M, Lynge E, Saraiya M, Segnan N, Sankaranarayanan R, Rajaraman P, Trimble E, Taplin S, Rath GK, Mehrotra R. Population-based cancer screening programmes in low-income and middle-income countries: regional consultation of the International Cancer Screening Network in India. Lancet Oncol 2018;19:e113-22. [PMID: 29413465 DOI: 10.1016/S1470-2045(18)30003-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 6.7] [Reference Citation Analysis]
8 Datta GD, Blair A, Sylvestre M, Gauvin L, Drouin M, Mayrand M. Cervical cancer screening in Montreal: Building evidence to support primary care and policy interventions. Preventive Medicine 2018;111:265-71. [DOI: 10.1016/j.ypmed.2018.02.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Cho YG. Socioeconomic Disparities in Cancer Screening: Organized versus Opportunistic. Korean J Fam Med 2016;37:261-2. [PMID: 27688857 DOI: 10.4082/kjfm.2016.37.5.261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Gianino MM, Lenzi J, Bonaudo M, Fantini MP, Siliquini R, Ricciardi W, Damiani G. Organized screening programmes for breast and cervical cancer in 17 EU countries: trajectories of attendance rates. BMC Public Health 2018;18:1236. [PMID: 30400786 DOI: 10.1186/s12889-018-6155-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
11 Taplin S. Foreword: Promoting cancer screening: Lessons learned and future directions for research and practice. Cancer 2004;101:1105-6. [DOI: 10.1002/cncr.20514] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
12 Garcia K, Crimmins EM. Cancer Screening in the U.S. and Europe: Policies, Practices, and Trends in Cancer Incidence and Mortality. In: Hoque N, Mcgehee MA, Bradshaw BS, editors. Applied Demography and Public Health. Dordrecht: Springer Netherlands; 2013. pp. 125-54. [DOI: 10.1007/978-94-007-6140-7_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Pruitt SL, Werner CL, Borton EK, Sanders JM, Balasubramanian BA, Barnes A, Betts AC, Skinner CS, Tiro JA. Cervical Cancer Burden and Opportunities for Prevention in a Safety-Net Healthcare System. Cancer Epidemiol Biomarkers Prev 2018;27:1398-406. [PMID: 30185535 DOI: 10.1158/1055-9965.EPI-17-0912] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
14 Tinmouth J, Patel J, Austin PC, Baxter NN, Brouwers MC, Earle C, Levitt C, Lu Y, Mackinnon M, Paszat L, Rabeneck L. Increasing participation in colorectal cancer screening: Results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders: Directly mailed gFOBT kits. Int J Cancer 2015;136:E697-703. [DOI: 10.1002/ijc.29191] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
15 Chan CW, Choi KC, Wong RS, Chow KM, So WK, Leung DY, Lam WW, Goggins W. Examining the Cervical Screening Behaviour of Women Aged 50 or above and Its Predicting Factors: A Population-Based Survey. Int J Environ Res Public Health 2016;13:E1195. [PMID: 27918456 DOI: 10.3390/ijerph13121195] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
16 Missinne S, Bracke P. Age differences in mammography screening reconsidered: life course trajectories in 13 European countries. Eur J Public Health 2015;25:314-20. [PMID: 24997204 DOI: 10.1093/eurpub/cku077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
17 François G, Van Roosbroeck S, Hoeck S, Markovskaia E, Van Hal G. A pivotal role for the general practitioner in a mixed mammographic screening model. Rev Epidemiol Sante Publique 2012;60:150-6. [PMID: 22424750 DOI: 10.1016/j.respe.2011.09.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
18 Machii R, Saika K, Higashi T, Aoki A, Hamashima C, Saito H. Evaluation of Feedback Interventions for Improving the Quality Assurance of Cancer Screening in Japan: Study Design and Report of the Baseline Survey. Japanese Journal of Clinical Oncology 2012;42:96-104. [DOI: 10.1093/jjco/hyr185] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
19 Smith RA, Manassaram-Baptiste D, Brooks D, Doroshenk M, Fedewa S, Saslow D, Brawley OW, Wender R. Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening. CA Cancer J Clin. 2015;65:30-54. [PMID: 25581023 DOI: 10.3322/caac.21261] [Cited by in Crossref: 235] [Cited by in F6Publishing: 209] [Article Influence: 33.6] [Reference Citation Analysis]
20 Chapple A, Ziebland S, Hewitson P, Mcpherson A. What affects the uptake of screening for bowel cancer using a faecal occult blood test (FOBt): A qualitative study. Social Science & Medicine 2008;66:2425-35. [DOI: 10.1016/j.socscimed.2008.02.009] [Cited by in Crossref: 92] [Cited by in F6Publishing: 81] [Article Influence: 6.6] [Reference Citation Analysis]
21 Jonah L, Pefoyo AK, Lee A, Hader J, Strasberg S, Kupets R, Chiarelli AM, Tinmouth J. Evaluation of the effect of an audit and feedback reporting tool on screening participation: The Primary Care Screening Activity Report (PCSAR). Prev Med 2017;96:135-43. [PMID: 27923667 DOI: 10.1016/j.ypmed.2016.12.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
22 Schreuders EH, Ruco A, Rabeneck L, Schoen RE, Sung JJ, Young GP, Kuipers EJ. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637-1649. [PMID: 26041752 DOI: 10.1136/gutjnl-2014-309086] [Cited by in Crossref: 508] [Cited by in F6Publishing: 488] [Article Influence: 72.6] [Reference Citation Analysis]
23 Baxter NN, Facey M, Ruco A, Baker NA, Sorvari A, Benmessaoud A, Dube C, Rabeneck L, Tinmouth J. Nimble Approach: fast, adapting, calculating and ethically mindful approach to managing colorectal cancer screening programmes during a pandemic. BMJ Open Gastroenterol 2022;9:e000826. [PMID: 35046092 DOI: 10.1136/bmjgast-2021-000826] [Reference Citation Analysis]
24 Puricelli Perin DM, Elfström KM, Bulliard JL, Burón A, Campbell C, Flugelman AA, Giordano L, Kamineni A, Ponti A, Rabeneck L, Saraiya M, Smith RA, Broeders MJM; International Cancer Screening Network. Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey. Prev Med 2021;151:106642. [PMID: 34217420 DOI: 10.1016/j.ypmed.2021.106642] [Reference Citation Analysis]
25 Smith RA, Oeffinger KC. The Importance of Cancer Screening. Med Clin North Am 2020;104:919-38. [PMID: 33099452 DOI: 10.1016/j.mcna.2020.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Kudo T, Kakizaki S, Sohara N, Onozato Y, Okamura S, Inui Y, Mori M. Analysis of ABC (D) stratification for screening patients with gastric cancer. World J Gastroenterol 2011; 17(43): 4793-4798 [PMID: 22147980 DOI: 10.3748/wjg.v17.i43.4793] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
27 Antinyan A, Bertoni M, Corazzini L. Cervical cancer screening invitations in low and middle income countries: Evidence from Armenia. Soc Sci Med 2021;273:113739. [PMID: 33609965 DOI: 10.1016/j.socscimed.2021.113739] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Fabrizio CS, Shea CM. Disseminating a cervical cancer screening program through primary physicians in Hong Kong: a qualitative study. BMC Health Serv Res 2014;14:85. [PMID: 24568606 DOI: 10.1186/1472-6963-14-85] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
29 Taylor L, Basro S, Apffelstaedt JP, Baatjes K. Time for a re-evaluation of mammography in the young? Results of an audit of mammography in women younger than 40 in a resource restricted environment. Breast Cancer Res Treat 2011;129:99-106. [PMID: 21698411 DOI: 10.1007/s10549-011-1630-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
30 Smith RA, Brooks D, Cokkinides V, Saslow D, Brawley OW. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin. 2013;63:88-105. [PMID: 23378235 DOI: 10.3322/caac.21174] [Cited by in Crossref: 167] [Cited by in F6Publishing: 145] [Article Influence: 18.6] [Reference Citation Analysis]
31 Ruco A, Baxter NN, Jacobson J, Tinmouth J, Llovet D. Using Facebook to promote the uptake of colorectal cancer screening. BMC Public Health 2022;22:323. [PMID: 35168576 DOI: 10.1186/s12889-022-12732-w] [Reference Citation Analysis]
32 Sivaram S, Perkins S, He M, Ginsburg E, Dominguez G, Vedham V, Katz F, Parascandola M, Bogler O, Gopal S. Building Capacity for Global Cancer Research: Existing Opportunities and Future Directions. J Cancer Educ 2021;36:5-24. [PMID: 34273100 DOI: 10.1007/s13187-021-02043-w] [Reference Citation Analysis]
33 Montagna G, Schneeberger AR, Rossi L, Reina H, Schwab FD, Schoetzau A, Eichholzer M, Pagani O, Weber WP, Kurzeder C, Güth U, Huber CG. The impact of depression on adherence to organized and opportunistic breast cancer screening. Eur J Cancer Prev 2020;29:53-9. [PMID: 30998527 DOI: 10.1097/CEJ.0000000000000520] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Robb KA. The integrated screening action model (I-SAM): A theory-based approach to inform intervention development. Prev Med Rep 2021;23:101427. [PMID: 34189020 DOI: 10.1016/j.pmedr.2021.101427] [Reference Citation Analysis]
35 Muradali D, Kennedy EB, Eisen A, Holloway CMB, Smith CR, Chiarelli AM. Breast screening for survivors of breast cancer: A systematic review. Prev Med 2017;103:70-5. [PMID: 28765083 DOI: 10.1016/j.ypmed.2017.07.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Yip CH, Smith RA, Anderson BO, Miller AB, Thomas DB, Ang ES, Caffarella RS, Corbex M, Kreps GL, McTiernan A; Breast Health Global Initiative Early Detection Panel. Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer 2008;113:2244-56. [PMID: 18837017 DOI: 10.1002/cncr.23842] [Cited by in Crossref: 148] [Cited by in F6Publishing: 116] [Article Influence: 11.4] [Reference Citation Analysis]
37 Smith RA, Oeffinger KC. Cancer Screening in Primary Care: So Much Progress, So Much Left to Do. Med Clin North Am 2020;104:xv-xvii. [PMID: 33099458 DOI: 10.1016/j.mcna.2020.09.002] [Reference Citation Analysis]
38 Sharma KP, DeGroff A, Scott L, Shrestha S, Melillo S, Sabatino SA. Correlates of colorectal cancer screening rates in primary care clinics serving low income, medically underserved populations. Prev Med 2019;126:105774. [PMID: 31319118 DOI: 10.1016/j.ypmed.2019.105774] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
39 Sankaranarayanan R. Screening for Cancer in Low- and Middle-Income Countries. Annals of Global Health 2018;80:412. [DOI: 10.1016/j.aogh.2014.09.014] [Cited by in Crossref: 105] [Cited by in F6Publishing: 98] [Article Influence: 13.1] [Reference Citation Analysis]
40 Stracci F. Cancer Screenings, Diagnostic Technology Evolution, and Cancer Control. In: Verma M, editor. Cancer Epidemiology. Totowa: Humana Press; 2009. pp. 107-36. [DOI: 10.1007/978-1-59745-416-2_6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
41 Smith RA, Fedewa S, Siegel R. Early colorectal cancer detection-Current and evolving challenges in evidence, guidelines, policy, and practices. Adv Cancer Res 2021;151:69-107. [PMID: 34148621 DOI: 10.1016/bs.acr.2021.03.005] [Reference Citation Analysis]
42 Yakubu M, Meggetto O, Lai Y, Peirson L, Walker M, Lofters A. Impact of postal correspondence letters on participation in cancer screening: a rapid review. Prev Med 2021;145:106404. [PMID: 33388326 DOI: 10.1016/j.ypmed.2020.106404] [Reference Citation Analysis]
43 De La Torre CL, Dumbauld JN, Haughton J, Gupta S, Nodora J, Giacinto RE, Ramers C, Bharti B, Wells K, Lopez J, Díaz M, Moody J, Arredondo EM. Development of a Group-Based Community Health Worker Intervention to Increase Colorectal Cancer Screening Among Latinos. Hisp Health Care Int 2021;19:47-54. [PMID: 32466687 DOI: 10.1177/1540415320923564] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Sala DCP, Okuno MFP, Taminato M, Castro CP, Louvison MCP, Tanaka OY. Breast cancer screening in Primary Health Care in Brazil: a systematic review. Rev Bras Enferm 2021;74:e20200995. [PMID: 34259730 DOI: 10.1590/0034-7167-2020-0995] [Reference Citation Analysis]
45 Wübker A. Explaining variations in breast cancer screening across European countries. Eur J Health Econ 2014;15:497-514. [PMID: 23744174 DOI: 10.1007/s10198-013-0490-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
46 Chiou S, Lu T. Changes in geographic variation in the uptake of cervical cancer screening in Taiwan: Possible effects of “leadership style factor”? Health Policy 2014;114:64-70. [DOI: 10.1016/j.healthpol.2013.06.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
47 Roobol MJ. Screening for prostate cancer: are organized screening programs necessary? Transl Androl Urol 2018;7:4-11. [PMID: 29594014 DOI: 10.21037/tau.2017.12.10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
48 Demyati E. Knowledge, Attitude, Practice, and Perceived Barriers of Colorectal Cancer Screening among Family Physicians in National Guard Health Affairs, Riyadh. Int J Family Med 2014;2014:457354. [PMID: 25328703 DOI: 10.1155/2014/457354] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
49 Pimple SA, Mishra GA. Global strategies for cervical cancer prevention and screening. Minerva Ginecol 2019;71. [DOI: 10.23736/s0026-4784.19.04397-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
50 Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011;33:101-110. [PMID: 21709143 DOI: 10.1093/epirev/mxr007] [Cited by in Crossref: 129] [Cited by in F6Publishing: 118] [Article Influence: 11.7] [Reference Citation Analysis]
51 Dogan K, Karatas M, Yakici E. A model for locating preventive health care facilities. Cent Eur J Oper Res 2020;28:1091-121. [DOI: 10.1007/s10100-019-00621-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Eisinger F, Cals L, Calazel-Benque A, Blay JY, Coscas Y, Dolbeault S, Namer M, Pivot X, Rixe O, Serin D, Roussel C, Morère JF; EDIFICE committee. Impact of organised programs on colorectal cancer screening. BMC Cancer 2008;8:104. [PMID: 18412950 DOI: 10.1186/1471-2407-8-104] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
53 Castells A. Choosing the optimal method in programmatic colorectal cancer screening: current evidence and controversies. Therap Adv Gastroenterol 2015;8:221-33. [PMID: 26136839 DOI: 10.1177/1756283X15578610] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
54 Kellen E, Putte GV, Van Steen A, Cloes E, Lousbergh D, Buntinx F, Van Limbergen E. Interval cancers in the beginning years of the breast cancer screening programme in the Belgian province of Limburg. Acta Clin Belg 2008;63:179-84. [PMID: 18714848 DOI: 10.1179/acb.2008.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
55 Stock C, Hoffmeister M, Birkner B, Brenner H. Inter-physician variation in follow-up colonoscopies after screening colonoscopy. PLoS One 2013;8:e69312. [PMID: 23874941 DOI: 10.1371/journal.pone.0069312] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
56 Abdullah F, Su TT. Applying the Transtheoretical Model to evaluate the effect of a call–recall program in enhancing Pap smear practice: A cluster randomized trial. Preventive Medicine 2013;57:S83-6. [DOI: 10.1016/j.ypmed.2013.02.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
57 Garcia M. Addressing overuse and overdiagnosis in colorectal cancer screening for average-risk individuals. Colorectal Cancer 2015;4:27-35. [DOI: 10.2217/crc.15.4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
58 Wender RC, Brawley OW, Fedewa SA, Gansler T, Smith RA. A blueprint for cancer screening and early detection: Advancing screening's contribution to cancer control. CA Cancer J Clin. 2019;69:50-79. [PMID: 30452086 DOI: 10.3322/caac.21550] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
59 Duijm LE, Groenewoud JH, Fracheboud J, Plaisier ML, Roumen RM, van Ineveld BM, van Beek M, de Koning HJ. Utilization and cost of diagnostic imaging and biopsies following positive screening mammography in the southern breast cancer screening region of the Netherlands, 2000-2005. Eur Radiol 2008;18:2390-7. [PMID: 18491102 DOI: 10.1007/s00330-008-1043-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
60 Park B, Choi KS, Lee YY, Jun JK, Seo HG. Trends in Cancer Screening Rates among Korean Men and Women: Results from the Korean National Cancer Screening Survey (KNCSS), 2004-2011. Cancer Res Treat. 2012;44:113-120. [PMID: 22802749 DOI: 10.4143/crt.2012.44.2.113] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
61 Melson JE, Imperiale TF, Itzkowitz SH, Llor X, Kochman ML, Grady WM, Schoen RE, Burke CA, Shaukat A, Rabeneck L, Ladabaum U, Bresalier R, Spiegel B, Yee J, Wang T, Lieberman D, Komanduri S, Muthusamy VR, Dey N. AGA White Paper: Roadmap for the Future of Colorectal Cancer Screening in the United States. Clin Gastroenterol Hepatol 2020;18:2667-2678.e2. [PMID: 32634626 DOI: 10.1016/j.cgh.2020.06.053] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
62 Shao YH, Albertsen PC, Shih W, Roberts CB, Lu-Yao GL. The impact of PSA testing frequency on prostate cancer incidence and treatment in older men. Prostate Cancer Prostatic Dis 2011;14:332-9. [PMID: 21709691 DOI: 10.1038/pcan.2011.29] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
63 Ghahramani S, Kasraei H, Shahabi S, Lankarani KB. Facilitating Factors and Barriers of Women's Cancer Screening in Iran: A Systematic Review. Int J Prev Med 2020;11:199. [PMID: 33815723 DOI: 10.4103/ijpvm.IJPVM_509_18] [Reference Citation Analysis]
64 El Bcheraoui C, Basulaiman M, Wilson S, Daoud F, Tuffaha M, AlMazroa MA, Memish ZA, Al Saeedi M, Mokdad AH. Breast cancer screening in Saudi Arabia: free but almost no takers. PLoS One. 2015;10:e0119051. [PMID: 25774520 DOI: 10.1371/journal.pone.0119051] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 6.6] [Reference Citation Analysis]
65 Lee EH, Lee HY, Choi KS, Jun JK, Park EC, Lee JS. Trends in Cancer Screening Rates among Korean Men and Women: Results from the Korean National Cancer Screening Survey (KNCSS), 2004-2010. Cancer Res Treat. 2011;43:141-147. [PMID: 22022290 DOI: 10.4143/crt.2011.43.3.141] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
66 Tinmouth J, Lansdorp-Vogelaar I, Allison JE. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut 2015;64:1327-37. [PMID: 26041750 DOI: 10.1136/gutjnl-2014-308074] [Cited by in Crossref: 89] [Cited by in F6Publishing: 94] [Article Influence: 12.7] [Reference Citation Analysis]
67 Skroumpelos A, Zavras D, Pavi E, Kyriopoulos J. Recommending organized screening programs for adults in Greece: A Delphi consensus study. Health Policy 2013;109:38-45. [DOI: 10.1016/j.healthpol.2012.08.003] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
68 Willems B, Bracke P. Participants, Physicians or Programmes: Participants' educational level and initiative in cancer screening. Health Policy 2018;122:422-30. [PMID: 29454541 DOI: 10.1016/j.healthpol.2018.02.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
69 Bastani R, Yabroff KR, Myers RE, Glenn B. Interventions to improve follow-up of abnormal findings in cancer screening. Cancer 2004;101:1188-200. [PMID: 15316914 DOI: 10.1002/cncr.20506] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 3.5] [Reference Citation Analysis]
70 Bryant H, Mai V. Impact of age-specific recommendation changes on organized breast screening programs. Prev Med 2011;53:141-3. [PMID: 21723313 DOI: 10.1016/j.ypmed.2011.06.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
71 Escribà-agüir V, Rodríguez-gómez M, Ruiz-pérez I. Effectiveness of patient-targeted interventions to promote cancer screening among ethnic minorities: A systematic review. Cancer Epidemiology 2016;44:22-39. [DOI: 10.1016/j.canep.2016.07.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
72 Smith RA, Caleffi M, Albert US, Chen TH, Duffy SW, Franceschi D, Nyström L; Global Summit Early Detection and Access to Care Panel. Breast cancer in limited-resource countries: early detection and access to care. Breast J 2006;12 Suppl 1:S16-26. [PMID: 16430395 DOI: 10.1111/j.1075-122X.2006.00200.x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 42] [Article Influence: 6.2] [Reference Citation Analysis]
73 Williams JH, Carter SM, Rychetnik L. 'Organised' cervical screening 45 years on: How consistent are organised screening practices? Eur J Cancer 2014;50:3029-38. [PMID: 25282406 DOI: 10.1016/j.ejca.2014.09.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
74 Smith RA, Manassaram-Baptiste D, Brooks D, Cokkinides V, Doroshenk M, Saslow D, Wender RC, Brawley OW. Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2014;64:30-51. [PMID: 24408568 DOI: 10.3322/caac.21212] [Cited by in Crossref: 118] [Cited by in F6Publishing: 115] [Article Influence: 14.8] [Reference Citation Analysis]
75 Rohan EA, Boehm JE, DeGroff A, Glover-Kudon R, Preissle J. Implementing the CDC's Colorectal Cancer Screening Demonstration Program: wisdom from the field. Cancer 2013;119 Suppl 15:2870-83. [PMID: 23868482 DOI: 10.1002/cncr.28162] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
76 Young GP, Symonds EL, Allison JE, Cole SR, Fraser CG, Halloran SP, Kuipers EJ, Seaman HE. Advances in Fecal Occult Blood Tests: the FIT revolution. Dig Dis Sci. 2015;60:609-622. [PMID: 25492500 DOI: 10.1007/s10620-014-3445-3] [Cited by in Crossref: 94] [Cited by in F6Publishing: 83] [Article Influence: 11.8] [Reference Citation Analysis]
77 Senore C, Malila N, Minozzi S, Armaroli P. How to enhance physician and public acceptance and utilisation of colon cancer screening recommendations. Best Pract Res Clin Gastroenterol. 2010;24:509-520. [PMID: 20833353 DOI: 10.1016/j.bpg.2010.06.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
78 Zapka J, Taplin SH, Ganz P, Grunfeld E, Sterba K. Multilevel factors affecting quality: examples from the cancer care continuum. J Natl Cancer Inst Monogr 2012;2012:11-9. [PMID: 22623591 DOI: 10.1093/jncimonographs/lgs005] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
79 Chang HC, Hsiung HY, Chen SI, Yen AM, Chen TH. Comparison of a community outreach service with opportunity screening for cervical cancer using Pap smears. J Public Health (Oxf) 2007;29:165-72. [PMID: 17389674 DOI: 10.1093/pubmed/fdm003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
80 Schneider IJ, Giehl MW, Boing AF, d'Orsi E. [Mammogram screening for breast cancer and associated factors in the South of Brazil: a based-population survey]. Cad Saude Publica 2014;30:1987-97. [PMID: 25317527 DOI: 10.1590/0102-311x00162313] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
81 Kaplan HG, Malmgren JA, Atwood MK. Breast cancer distant recurrence lead time interval by detection method in an institutional cohort. BMC Cancer 2020;20:1124. [PMID: 33218313 DOI: 10.1186/s12885-020-07609-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Young GP, Senore C, Mandel JS, Allison JE, Atkin WS, Benamouzig R, Bossuyt PM, Silva MD, Guittet L, Halloran SP, Haug U, Hoff G, Itzkowitz SH, Leja M, Levin B, Meijer GA, O'Morain CA, Parry S, Rabeneck L, Rozen P, Saito H, Schoen RE, Seaman HE, Steele RJ, Sung JJ, Winawer SJ. Recommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer. Cancer 2016;122:826-39. [PMID: 26828588 DOI: 10.1002/cncr.29865] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
83 Verma M, Sarfaty M, Brooks D, Wender RC. Population-based programs for increasing colorectal cancer screening in the United States: Population Based Programs: CRC Screening. CA: A Cancer Journal for Clinicians 2015;65:496-510. [DOI: 10.3322/caac.21295] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
84 Duijm LE, Groenewoud JH, Fracheboud J, van Ineveld BM, Roumen RM, de Koning HJ. Introduction of additional double reading of mammograms by radiographers: Effects on a biennial screening programme outcome. European Journal of Cancer 2008;44:1223-8. [DOI: 10.1016/j.ejca.2008.03.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
85 Meissner HI, Vernon SW, Rimer BK, Wilson KM, Rakowski W, Briss PA, Smith RA. The future of research that promotes cancer screening. Cancer 2004;101:1251-9. [DOI: 10.1002/cncr.20510] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
86 Apffelstaedt JP, Steenkamp V, Baatjes KJ. Surgeon-read screening mammography: an analysis of 11,948 examinations. Ann Surg Oncol 2010;17 Suppl 3:249-54. [PMID: 20853042 DOI: 10.1245/s10434-010-1241-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
87 Garrido-cumbrera M, Borrell C, Palència L, Espelt A, Rodríguez-sanz M, Pasarín MI, Kunst A. Social Class Inequalities in the Utilization of Health Care and Preventive Services in Spain, a Country with a National Health System. Int J Health Serv 2010;40:525-42. [DOI: 10.2190/hs.40.3.h] [Cited by in Crossref: 51] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
88 Young GP. Population-based screening for colorectal cancer: Australian research and implementation. J Gastroenterol Hepatol 2009;24 Suppl 3:S33-42. [PMID: 19799696 DOI: 10.1111/j.1440-1746.2009.06069.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
89 Stock C, Holleczek B, Hoffmeister M, Stolz T, Stegmaier C, Brenner H. Adherence to physician recommendations for surveillance in opportunistic colorectal cancer screening: the necessity of organized surveillance. PLoS One 2013;8:e82676. [PMID: 24324821 DOI: 10.1371/journal.pone.0082676] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
90 Mizuno S, Miki I, Ishida T, Yoshida M, Onoyama M, Azuma T, Habu Y, Inokuchi H, Ozasa K, Miki K. Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis. Dig Dis Sci. 2010;55:3132-3137. [PMID: 20204698 DOI: 10.1007/s10620-010-1154-0] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 5.8] [Reference Citation Analysis]
91 Thewes B, McCaffery K, Davis E, Garvey G. Insufficient evidence on health literacy amongst Indigenous people with cancer: a systematic literature review. Health Promot Int 2018;33:195-218. [PMID: 27543930 DOI: 10.1093/heapro/daw066] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
92 Kim J, Lee S, Bae S, Choi MY, Lee J, Jung SP, Kim S, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH. Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes. Breast Cancer Res Treat 2012;131:527-40. [PMID: 22042364 DOI: 10.1007/s10549-011-1836-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
93 Pornet C, Dejardin O, Morlais F, Bouvier V, Launoy G. Socioeconomic and healthcare supply statistical determinants of compliance to mammography screening programs: A multilevel analysis in Calvados, France. Cancer Epidemiology 2010;34:309-15. [DOI: 10.1016/j.canep.2010.03.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
94 Hamashima C, Saito H, Sobue T. Awareness of and adherence to cancer screening guidelines among health professionals in Japan. Cancer Science 2007;98:1241-7. [DOI: 10.1111/j.1349-7006.2007.00512.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
95 Skrobanski H, Ream E, Poole K, Whitaker KL. Understanding primary care nurses' contribution to cancer early diagnosis: A systematic review. Eur J Oncol Nurs 2019;41:149-64. [PMID: 31358248 DOI: 10.1016/j.ejon.2019.06.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
96 Willems B, Bracke P. The education gradient in cancer screening participation: a consistent phenomenon across Europe? Int J Public Health 2018;63:93-103. [DOI: 10.1007/s00038-017-1045-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
97 Rabeneck L, Lansdorp-Vogelaar I. Assessment of a cancer screening program. Best Pract Res Clin Gastroenterol 2015;29:979-85. [PMID: 26651258 DOI: 10.1016/j.bpg.2015.09.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
98 Smith RA, Brawley OW. The National Breast and Cervical Cancer Early Detection Program: toward a system of cancer screening in the United States. Cancer 2014;120 Suppl 16:2617-9. [PMID: 25099906 DOI: 10.1002/cncr.28828] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
99 Diaz A, Kang J, Moore SP, Baade P, Langbecker D, Condon JR, Valery PC. Association between comorbidity and participation in breast and cervical cancer screening: A systematic review and meta-analysis. Cancer Epidemiology 2017;47:7-19. [DOI: 10.1016/j.canep.2016.12.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
100 Kalyta A, De Vera MA, Peacock S, Telford JJ, Brown CJ, Donnellan F, Gill S, Loree JM. Canadian Colorectal Cancer Screening Guidelines: Do They Need an Update Given Changing Incidence and Global Practice Patterns? Curr Oncol 2021;28:1558-70. [PMID: 33919428 DOI: 10.3390/curroncol28030147] [Reference Citation Analysis]
101 Schoueri-Mychasiw N, Campbell S, Mai V. Increasing screening mammography among immigrant and minority women in Canada: a review of past interventions. J Immigr Minor Health 2013;15:149-58. [PMID: 22466249 DOI: 10.1007/s10903-012-9612-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
102 Correia A, Rabeneck L, Baxter NN, Paszat LF, Sutradhar R, Yun L, Tinmouth J. Lack of follow-up colonoscopy after positive FOBT in an organized colorectal cancer screening program is associated with modifiable health care practices. Prev Med 2015;76:115-22. [PMID: 25895843 DOI: 10.1016/j.ypmed.2015.03.028] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
103 Duffy SW, Smith RA, Gabe R, Tabár L, Yen AM, Chen TH. Screening for Breast Cancer. Surgical Oncology Clinics of North America 2005;14:671-97. [DOI: 10.1016/j.soc.2005.06.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
104 Altobelli E, Rapacchietta L, Marziliano C, Campagna G, Profeta VF, Fagnano R. Differences in colorectal cancer surveillance epidemiology and screening in the WHO European Region. Oncol Lett. 2019;17:2531-2542. [PMID: 30675315 DOI: 10.3892/ol.2018.9851] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
105 Chamot E, Charvet AI, Perneger TV. Who gets screened, and where: A comparison of organised and opportunistic mammography screening in Geneva, Switzerland. European Journal of Cancer 2007;43:576-84. [DOI: 10.1016/j.ejca.2006.10.017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
106 Lousquy R, Delpech Y, Barranger E. Place du ganglion sentinelle dans la stratégie thérapeutique du cancer du col de l’utérus aux stades précoces. Gynécologie Obstétrique & Fertilité 2009;37:827-33. [DOI: 10.1016/j.gyobfe.2009.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
107 Mehta SJ, Jensen CD, Quinn VP, Schottinger JE, Zauber AG, Meester R, Laiyemo AO, Fedewa S, Goodman M, Fletcher RH, Levin TR, Corley DA, Doubeni CA. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System. J Gen Intern Med 2016;31:1323-30. [PMID: 27412426 DOI: 10.1007/s11606-016-3792-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
108 Tinmouth J, Llovet D, Sutradhar R, Tsiplova K, Roushani J, Lee A, Hader J, Rabeneck L, Paszat L. Two randomized controlled trials for colorectal cancer screening invitations developed using a behavioral science approach. Prev Med 2021;155:106918. [PMID: 34953810 DOI: 10.1016/j.ypmed.2021.106918] [Reference Citation Analysis]
109 Speight PM, Epstein J, Kujan O, Lingen MW, Nagao T, Ranganathan K, Vargas P. Screening for oral cancer-a perspective from the Global Oral Cancer Forum. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;123:680-687. [PMID: 27727113 DOI: 10.1016/j.oooo.2016.08.021] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
110 Walsh B, Silles M, O’neill C. The importance of socio-economic variables in cancer screening participation: A comparison between population-based and opportunistic screening in the EU-15. Health Policy 2011;101:269-76. [DOI: 10.1016/j.healthpol.2011.02.001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 4.6] [Reference Citation Analysis]
111 Chamot E, Charvet A, Perneger TV. Overuse of mammography during the first round of an organized breast cancer screening programme. J Eval Clin Pract 2009;15:620-5. [PMID: 19522725 DOI: 10.1111/j.1365-2753.2008.01062.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
112 Unanue-Arza S, Solís-Ibinagagoitia M, Díaz-Seoane M, Mosquera-Metcalfe I, Idigoras I, Bilbao I, Portillo I. Inequalities and risk factors related to non-participation in colorectal cancer screening programmes: a systematic review. Eur J Public Health 2021;31:346-55. [PMID: 33313657 DOI: 10.1093/eurpub/ckaa203] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
113 Pankakoski M, Heinävaara S, Anttila A, Sarkeala T. Differences in cervical test coverage by age, socioeconomic status, ethnic origin and municipality type - A nationwide register-based study. Prev Med 2020;139:106219. [PMID: 32693176 DOI: 10.1016/j.ypmed.2020.106219] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
114 del Junco DJ, Vernon SW, Coan SP, Tiro JA, Bastian LA, Savas LS, Perz CA, Lairson DR, Chan W, Warrick C, McQueen A, Rakowski W. Promoting regular mammography screening I. A systematic assessment of validity in a randomized trial. J Natl Cancer Inst 2008;100:333-46. [PMID: 18314473 DOI: 10.1093/jnci/djn027] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
115 Rabeneck L, Horton S, Zauber AG, Earle C. Colorectal Cancer. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Disease Control Priorities, Third Edition (Volume 3): Cancer. The World Bank; 2015. pp. 101-19. [DOI: 10.1596/978-1-4648-0349-9_ch6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
116 Viuff JH, Vejborg I, Schwartz W, Bak M, Mikkelsen EM. Morbidity as a Predictor for Participation in the Danish National Mammography Screening Program: A Cross-Sectional Study. Clin Epidemiol 2020;12:509-18. [PMID: 32547242 DOI: 10.2147/CLEP.S250418] [Reference Citation Analysis]
117 Mizuno S, Kobayashi M, Tomita S, Miki I, Masuda A, Onoyama M, Habu Y, Inokuchi H, Watanabe Y. Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. Gastric Cancer. 2009;12:158-163. [PMID: 19890696 DOI: 10.1007/s10120-009-0522-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
118 Beckmann KR, Roder DM, Hiller JE, Farshid G, Lynch JW. Do breast cancer risk factors differ among those who do and do not undertake mammography screening? J Med Screen 2013;20:208-19. [DOI: 10.1177/0969141313510293] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
119 Kim BJ, Heo C, Kim BK, Kim JY, Kim JG. Effectiveness of gastric cancer screening programs in South Korea: Organized vs opportunistic models. World J Gastroenterol 2013; 19(5): 736-741 [PMID: 23430471 DOI: 10.3748/wjg.v19.i5.736] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
120 Waller J, Macedo A, von Wagner C, Simon AE, Jones C, Hammersley V, Weller D, Wardle J, Campbell C. Communication about colorectal cancer screening in Britain: public preferences for an expert recommendation. Br J Cancer 2012;107:1938-43. [PMID: 23175148 DOI: 10.1038/bjc.2012.512] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
121 Willems B, Bracke P. The impact of regional screening policies on the diffusion of cancer screening participation in Belgium: time trends in educational inequalities in Flanders and Wallonia. BMC Health Serv Res 2018;18:943. [PMID: 30514273 DOI: 10.1186/s12913-018-3746-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
122 Tinmouth J, Baxter NN, Paszat LF, Rabeneck L, Sutradhar R, Yun L. Using physician-linked mailed invitations in an organised colorectal cancer screening programme: effectiveness and factors associated with response. BMJ Open 2014;4:e004494. [PMID: 24622950 DOI: 10.1136/bmjopen-2013-004494] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
123 Chiou ST, Wu CY, Hurng BS, Lu TH. Changes in the magnitude of social inequality in the uptake of cervical cancer screening in Taiwan, a country implementing a population-based organized screening program. Int J Equity Health 2014;13:4. [PMID: 24405587 DOI: 10.1186/1475-9276-13-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
124 Marlow LAV, Chorley AJ, Haddrell J, Ferrer R, Waller J. Understanding the heterogeneity of cervical cancer screening non-participants: Data from a national sample of British women. Eur J Cancer 2017;80:30-8. [PMID: 28535495 DOI: 10.1016/j.ejca.2017.04.017] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
125 Brenner H, Hoffmeister M. [Colorectal cancer screening: evidence and implementation]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57:302-306. [PMID: 24562704 DOI: 10.1007/s00103-013-1911-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
126 Lim SM, Lee HY, Choi KS, Jun JK, Park EC, Kim Y, Han MA, Oh DK, Shim JI. Trends of mammography use in a national breast cancer screening program, 2004-2008. Cancer Res Treat 2010;42:199-202. [PMID: 21253321 DOI: 10.4143/crt.2010.42.4.199] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]